Quality & Science

The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

ASAM will publish the update to the National Practice Guideline in the March/April 2020 issue of the Journal of Addiction Medicine.

For future updates, please subscribe here.

ASAM the 2015 developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder, and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.

2015 National Practice Guideline

Access the full ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use in journal format.

Pocket Guide and App

Official ASAM National Practice Guideline quick-reference tools provide healthcare providers with instant access to current guideline in a clear concise format.

Slide Deck

The ASAM National Practice Guideline Slide Deck is a PowerPoint presentation on the guideline with notes from the speaker.

JAM Article

The Journal of Addiction Medicine features an article on the National Practice Guideline that describes the rationale and process for creating this guideline, and summarizes the recommendations.